Standardising care for hepatitis delta in the Netherlands

Recruiting

• Conditions: hepatitis D; 10019654; 10047438

• Registration Number: NL-OMON56445
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

- Active hepatitis delta based on a positive anti-HDV and a positive HDV-RNA
test
- Patients must be >=18 years
- Written informed consent

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Generate prospective population based follow-up data of a homogeneously managed<br /><br>hepatitis delta cohortGenerate prospective population based follow-up data of a<br /><br>homogeneously managed hepatitis delta cohort<br /><br><br /><br>Incidence of liver related events (liver cancer, (decompensation of) cirrhosis,<br /><br>liver transplantation) during follow-up and changes in markers of viral<br /><br>replication, inflammatory activity and liver stiffness over time.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Compare the outcomes of this cohort to a historic cohort identified in the<br /><br>DREAM-1 project</p><br>